{"id":4493,"date":"2015-08-06T12:26:55","date_gmt":"2015-08-06T12:26:55","guid":{"rendered":"http:\/\/www.420magazine.com\/?p=3624"},"modified":"2015-08-06T12:26:55","modified_gmt":"2015-08-06T12:26:55","slug":"study-shows-cannabis-alleviates-neuropathic-pain-in-those-with-diabetes","status":"publish","type":"post","link":"https:\/\/cannitrol.com\/blog\/study-shows-cannabis-alleviates-neuropathic-pain-in-those-with-diabetes\/","title":{"rendered":"Study Shows Cannabis Alleviates Neuropathic Pain In Those With Diabetes"},"content":{"rendered":"<div id=\"wp_fb_like_button\" style=\"margin:5px 0 5px 5px;float:right;height:100px;\"><script src=\"http:\/\/connect.facebook.net\/en_US\/all.js#xfbml=1\"><\/script><fb:like href=\"https:\/\/cannitrol.com\/blog\/study-shows-cannabis-alleviates-neuropathic-pain-in-those-with-diabetes\/\" send=\"true\" layout=\"standard\" width=\"450\" show_faces=\"false\" font=\"arial\" action=\"like\" colorscheme=\"light\"><\/fb:like><\/div><p>A small trial shows a dose-dependent reduction in peripheral neuropathic pain in patients with diabetes, according to a study published in the July issue of The Journal of Pain.<\/p>\n<p>Mark S. Wallace, M.D., from the University of California in San Diego, and colleagues conducted a randomized trial in 16 patients with painful diabetic peripheral neuropathy. They examined the short-term efficacy and tolerability of inhaled cannabis; each participant was exposed to four single dosing sessions of placebo or to low, medium, or high doses of cannabis in a crossover design. The authors performed baseline spontaneous pain, evoked pain, and cognitive testing. Subjects were administered aerosolized cannabis or placebo and the pain intensity and subjective &#8220;highness&#8221; score was measured during the first hour and for an additional three hours.<\/p>\n<p>The researchers found that spontaneous pain scores were significantly different between doses (P &lt; 0.001).<\/p>\n<p>Comparisons between placebo and low, medium, and high doses were significant (P = 0.031, 0.04, and &lt; 0.001, respectively), as were those between high versus low and medium doses (both P &lt; 0.001). The high dose had a significant effect on foam brush and von Frey evoked pain (P &lt; 0.001). The high dose had a significant negative effect (impaired performance) on two of the three neuropsychological tests.<\/p>\n<p>&#8220;This adds preliminary evidence to support further research on the efficacy of the cannabinoids in neuropathic pain,&#8221; the authors write.<\/p>\n<p><img src=\"http:\/\/www.420magazine.com\/gallery\/data\/1412\/14575.jpg\" alt=\"\" border=\"0\" \/><\/p>\n<p>News Moderator: Jacob Redmond <a href=\"http:\/\/www.420magazine.com\/\" target=\"_blank\">420 MAGAZINE \u00ae<\/a><br \/>\nFull Article: <a href=\"http:\/\/medicalxpress.com\/news\/2015-07-cannabis-alleviates-peripheral-neuropathic-pain.html\" target=\"_blank\">Cannabis alleviates peripheral neuropathic pain in diabetes<\/a><br \/>\nAuthor: Web Staff<br \/>\nContact: <a href=\"http:\/\/medicalxpress.com\/help\/feedback\/\" target=\"_blank\">Medical Xpress : Help Center<\/a><br \/>\nPhoto Credit: None Found<br \/>\nWebsite: <a href=\"http:\/\/medicalxpress.com\/\" target=\"_blank\">Medical Xpress &#8211; medical research advances and health news<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A small trial shows a dose-dependent reduction in peripheral neuropathic pain in patients with diabetes, according to a study published&#8230; <a href=\"http:\/\/www.420magazine.com\/2015\/08\/study-shows-cannabis-alleviates-neuropathic-pain-in-those-with-diabetes\/\" class=\"read-more\">[Read More]<\/a> <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[2329,9,1,3],"tags":[4896],"_links":{"self":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/posts\/4493"}],"collection":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/comments?post=4493"}],"version-history":[{"count":0,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/posts\/4493\/revisions"}],"wp:attachment":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/media?parent=4493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/categories?post=4493"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/tags?post=4493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}